In 2016, MET-Rx, the world's leading comprehensive operator of high-quality nutritional supplements, established a joint venture with NBTY and obtained the permanent right to operate and use the trademark of Merix in the Chinese market
In 2006, MET-Rx® officially landed in China and was distributed by Nuotianyuan (China) Trading Co., Ltd. Since there is no intermediate link, Merrix products are reasonably priced and the quality is guaranteed, so that more fitness enthusiasts can experience the effect of "sports + nutrition" with half the effort.
MET-Rx® is the world's largest manufacturer and seller of professional functional foods, NBTY, a leading sports nutrition brand in the world. MET-Rx® was originally founded by Scott Connelly, MD, professor of neurophysiology at Boston University. After years of research, Dr. Connelly developed the core protein formula of MET-Rx® products, Metamyosin's patented formula protein, which immediately received positive response and high praise from the world's top athletes, Hollywood stars, and many fitness enthusiasts. Since then, MET-Rx® has launched several series of protein, amino acid, fat burning and other products, which are used in the strength, shape and endurance training of professional and amateur athletes. Since 1977, MET-Rx® has been the exclusive title sponsor of the World's Strongest Man, showcasing performances from all over the world every year and broadcasting them on ESPN and other sports channels. MET-Rx's® quality and technique have been recognized by several of the world's top athletes, including professional bodybuilder Dixsta, who won the Arnold Classic in 2005 and 2006 for two consecutive years. Jackson, three-time World Hercules Champion World Super Hercules Myris.
On March 11, 2016, By-Health established a joint venture with NBTY, one of the world's largest dietary supplement companies, to obtain the permanent operation rights and trademark rights of Nature's Bounty and Met-RX in the Chinese market.
It is reported that in this joint venture, Tomson Beijian plans to inject 80 million to 120 million yuan, with a shareholding ratio of 60%; NBTY will inject the business of the existing Natures Bounty and Met-RX brands in the Chinese market, as well as the cross-border e-commerce business, into the joint venture, with a 40% stake. Tang Hui, the chairman of Tomson Beijian Pharmaceutical Co., Ltd., will serve as the chairman of the joint venture, the CEO and the main management team will be dispatched by Tomson Beijian, and NBTY will send the CFO and part of the team.
